News

diabetic macular edema
Eylea HD receives approval for dosing interval extension
This updated dosing schedule means that wet AMD and DME patients can now have their treatment plans tailored to their individual needs.

Axpaxli
Successful Phase 3 study results for Ocular's Axpaxli wet AMD drug
Ocular Therpeutix announced successful results of their experimental drug Axpaxli in treating wet age-related macular degeneration.

age related macular degeneration
Parkinson's medication may help lower risk progression of age-related macular degeneration
Levodopa is commonly prescribed to treat Parkinson's disease and a recent study found that it could possibly reduce the risk of progression from dry age-related macular degeneration (AMD) to the we...

age related macular degeneration
Possible link between Psorias and risk of developing age-related macular degeneration
Study findings demonstrated a link between psoriasis and both dry and wet macular degeneration.

diabetic macular edema
Eydenzelt receives FDA approval for four retinal diseases
Eydenzelt is approved for use in treating wet age-related macular degeneration, macular edema following reetinal vein occlusion, diabetic macular edema and diabetic retinopathy.

low vision
Getting help for your wet AMD with smartphone Apps
For people trying to manage their wet AMD symptoms, utilizing phone apps may help with making every day tasks easier.

sleep apnea
Wet AMD risk linked to sleep apnea
Researchers at the Center for Eye Research in Australia have discovered a possible link between moderate-to-severe obstructive sleep apnea (OSA) and wet age-related macular degeneration.

age-related macular degeneration
Researchers working on possible alternative treatment for wet AMD
Researchers have recently discovered that the enzyme, telomerase, plays a role in abnormal blood vessel formation in lab mice and this discovery may lead to new therapies in treating the wet form ...
